Pearlie Chong, M.D.
Associate Professor

Dr. Pearlie Chong received her M.D. in 2006 at the Schulich School of Medicine & Dentistry at Western University in London, Ontario, Canada. After obtaining her M.D. Dr. Chong completed an Internal Medicine Residency at Lehigh Valley Health Network in Allentown, Pennsylvania and an Infectious Diseases Fellowship at Georgetown University Medical Center. Dr. Chong developed a strong interest in Transplant Infectious Diseases while at Georgetown and went on to complete a Transplant Infectious Diseases Fellowship at Mayo Clinic, Rochester, Minnesota. 

At the completion of her fellowships, Dr. Chong was recruited to the Division of Infectious Diseases at the University of North Carolina as Clinical Assistant Professor of Medicine to co-create the Immunocompromised Host Infectious Diseases Program. While at UNC, Dr. Chong improved the quality of care delivered to solid organ transplant, bone marrow transplant patients and patients with hematologic malignancies by her active participation on the inpatient consult service and clinics. She also successfully developed protocols, was the Immunocompromised Host ID representative at the Anti-Infective Subcommittee Meeting of the UNC Pharmacy and Therapeutics Committee and worked collaboratively with the Center for International Blood and Marrow Transplant Research (CIBMTR) Infectious Diseases Working Committee to improve the quality of data collection forms for all transplant recipients. 

Dr. Chong brings to UTSW a strong background in Transplant Infectious Diseases. Her clinical practice emphasizes evidence-based, patient-centered care with a multidisciplinary approach. Dr. Chong is passionate about addressing clinical questions that arise in the day-to-day care of transplant patients and believes that advances in clinical research will help prevent and treat infectious complications in immunocompromised individuals. She is currently working on completing her Master of Science in Clinical Research through the Gillings School of Public Health at UNC.

Medical School

Western University Canada (2006)

Residency

Lehigh Valley Health Network (2009), Internal Medicine

Fellowship

Georgetown University Hospital (2012), Infectious Diseases

Fellowship

Mayo Clinic (2013), Transplant Infectious Diseases

• Clinical Research Related to Infections in Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients
• Study Design and Data Analyses

Featured Publications

Live vaccines after pediatric solid organ transplant: Proceedings of a consensus meeting, 2018.

Suresh S, Upton J, Green M, Pham-Huy A, Posfay-Barbe KM, Michaels MG, Top KA, Avitzur Y, Burton C, Chong PP, Danziger-Isakov L, Dipchand AI, Hébert D, Kumar D, Morris SK, Nalli N, Ng VL, Nicholas SK, Robinson JL, Solomon M, Tapiero B, Verma A, Walter JE, Allen UD, Pediatr Transplant 2019 Nov 23 7 e13571

Pharmacodynamics of daptomycin in combination with other antibiotics for the treatment of enterococcal bacteraemia.

Avery LM, Kuti JL, Weisser M, Egli A, Rybak MJ, Zasowski EJ, Arias CA, Contreras GA, Chong PP, Aitken SL, DiPippo AJ, Wang JT, Britt NS, Nicolau DP, Int. J. Antimicrob. Agents 2019 Sep 54 3 346-350

Norovirus in health care and implications for the immunocompromised host.

Chong PP, Atmar RL, Curr. Opin. Infect. Dis. 2019 Aug 32 4 348-355

The gut microbiota in transplant patients.

Chong PP, Koh AY, Blood Rev. 2019 Aug 100614

Reply to Cheng and Chuang.

Avery LM, Kuti JL, Weisser M, Egli A, Rybak MJ, Zasowski EJ, Arias CA, Contreras GA, Chong PP, Aitken SL, DiPippo AJ, Wang JT, Britt NS, Nicolau DP Clin. Infect. Dis. 2019 Jan

Pharmacodynamic Analysis of Daptomycin-Treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint.

Avery LM, Kuti JL, Weisser M, Egli A, Rybak MJ, Zasowski EJ, Arias CA, Contreras GA, Chong PP, Aitken SL, DiPippo AJ, Wang JT, Britt NS, Nicolau DP Clin. Infect. Dis. 2018 Sep

Clinical presentation and outcomes of norovirus infection in intestinal allograft compared to native intestine.

Florescu DF, Sonderup JL, Grant W, Chong PP, van Duin D, Kalil AC Transpl Infect Dis 2017 Mar

Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.

Chong PP, van Duin D, Bangdiwala A, Ivanova A, Miller WC, Weber DJ, Gilligan PH, Shea TC Clin Ther 2016 Nov 38 11 2468-2476

Predictors of persistent diarrhea in norovirus enteritis after solid organ transplantation.

Chong PP, van Duin D, Sonderup JL, Grant WJ, Kalil AC, Florescu DF Clin Transplant 2016 Nov 30 11 1488-1493

Increasing Rates of Fluoroquinolone Resistance in Escherichia coli Isolated From the Blood and Urine of Patients with Hematologic Malignancies and Stem Cell Transplant Recipients.

Hauck CG, Chong PP, Miller MB, Jamieson K, Fine JP, Foster MC, Shea TC, van Duin D Pathog Immun 2016 Fall-Winter 1 2 234-242

• Best (Trainee) Abstract Award
  Thoracic and Critical Care Community of Practice, American Society of Transplantation, World Transplant Congress (2014)
• ID Week Trainee Award Grant
  Infectious Diseases Week (2013)
• Poster of Distinction Award
  American Transplant Congress, Seattle, WA (2013)
• State Champion Team
  American College of Physicians Medical Jeopardy (2009)
• Dean's List for High Academic Achievement
  International Medical University, Malaysia (2003)

• Transplant Infectious Diseases Special Interest Group, American Society of Bone Marrow Transplantation (ASBMT) (2014)
• Infectious Diseases Society of America (2010)
• Center for International Blood and Marrow Transplant Research (CIBMTR), Infectious Diseases Working Group (1214)